These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10987606)
41. [Anti-arrhythmic drugs interaction and defibrillation threshold in patients with implantable cardioverter defibrillator]. de Vasconcelos JT; Galvão Filho Sdos S; Barcellos CM Arq Bras Cardiol; 2003 Mar; 80(3):336-9. PubMed ID: 12856278 [No Abstract] [Full Text] [Related]
42. [Utilization of implantable ventricular defibrillators (with an analysis of the value of antiarrhythmics in the treatment of potentially fatal ventricular arrhythmias]. Waleffe A Rev Med Liege; 2000 Apr; 55(4):307-14. PubMed ID: 10909319 [TBL] [Abstract][Full Text] [Related]
43. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Sweeney MO Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472 [No Abstract] [Full Text] [Related]
44. Management of malignant ventricular arrhythmias and cardiac arrest. Fogel RI; Prystowsky EN Crit Care Med; 2000 Oct; 28(10 Suppl):N165-9. PubMed ID: 11055686 [TBL] [Abstract][Full Text] [Related]
45. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee. Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527 [No Abstract] [Full Text] [Related]
46. Ventricular arrhythmias. Preventing sudden death with drugs and ICD devices. Doherty JU; Fuchs S; Tecce MA Geriatrics; 2000 Aug; 55(8):26-8, 31-2, 35-6. PubMed ID: 10953684 [TBL] [Abstract][Full Text] [Related]
47. [Fundamental principle in therapy for arrhythmia]. Atarashi H Nihon Naika Gakkai Zasshi; 2006 Feb; 95(2):228-33. PubMed ID: 16536071 [No Abstract] [Full Text] [Related]
48. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
56. Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology. Eur Heart J; 1992 Oct; 13(10):1304-10. PubMed ID: 1396800 [No Abstract] [Full Text] [Related]
58. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022 [TBL] [Abstract][Full Text] [Related]
59. Prospective trials of implantable cardioverter defibrillators versus drugs: are they addressing the right question? Josephson M; Nisam S Am J Cardiol; 1996 Apr; 77(10):859-63. PubMed ID: 8623740 [No Abstract] [Full Text] [Related]